ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,687Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 231

$779K Total Retail Price of All Prescriptions

Rank: 8 out of 231

592 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
33% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Delaware
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 592 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

10% of this provider’s 592 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 6,743 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$90 was the average price of a prescription from this provider, compared to $74 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Delaware
LISINOPRIL 361 294 1 1
SIMVASTATIN 346 304 2 2
LEVOTHYROXINE SODIUM 266 213 3 3
OMEPRAZOLE 202 148 4 5
ATENOLOL 200 159 5 11
AMLODIPINE BESYLATE 173 146 6 4
FUROSEMIDE 166 132 7 6
ZOLPIDEM TARTRATE 166 133 7 14
HYDROCODONE-ACETAMINOPHEN 164 88 S3 9 21
ATORVASTATIN CALCIUM 163 131 10 8
CRESTOR 159 111 11 19
CITALOPRAM HBR 153 99 12 20
HYDROCHLOROTHIAZIDE 129 101 13 9
METFORMIN HCL 125 100 14 7
GABAPENTIN 114 85 15 15
METOPROLOL TARTRATE 110 93 16 12
SYNTHROID 103 84 17 28
SERTRALINE HCL 99 89 18 18
TRAZODONE HCL 96 52 19 35
NEXIUM 87 62 20 31
METOPROLOL SUCCINATE 80 60 21 13
OXYCODONE HCL 79 59 S2 22 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 77 74 23 22
FLUOXETINE HCL 76 71 24 67
LOSARTAN POTASSIUM 75 62 25 29
TRAMADOL HCL 74 62 26 16
SPIRIVA 74 59 26 61
ADVAIR DISKUS 65 60 28 50
PRAVASTATIN SODIUM 64 58 29 10
PROAIR HFA 63 53 30 59
DIOVAN 60 50 31 27
CYMBALTA 58 31 32 46
DICLOFENAC SODIUM 56 54 33 215
MIRTAZAPINE 56 48 33 25
PREDNISONE 55 45 35 41
RANITIDINE HCL 52 40 36 51
AMOXICILLIN 51 44 37 113
PANTOPRAZOLE SODIUM 51 27 37 62
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.